House Dems Say FDA ‘Inappropriately Collaborated’ With Biogen on New Alzheimer’s Drug

House Dems Say FDA ‘Inappropriately Collaborated’ With Biogen on New Alzheimer’s Drug “I am hopeful these findings are a wake-up call for FDA to reform its practices and a call to action to my congressional colleagues to continue oversight of the pharmaceutical industry to ensure they don’t put profits over patients,” said Rep. Carolyn Maloney. Brett Wilkins Dec 30, 2022 Nearly two years after a leading U.S. consumer advocacy group sounded the alarm on the matter, House Democrats …Source

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

Powered by WordPress | Designed by: Premium WordPress Themes | Thanks to Themes Gallery, Bromoney and Wordpress Themes